Intracranial pressure (ICP) monitoring uses a device placed inside the head. The monitor senses the pressure inside the skull and sends measurements to a recording device. The monitoring of intracranial pressure is used in treating severe traumatic brain injury patients. This process is called intracranial pressure monitoring. All current clinical available measurement methods are invasive and use various transducer systems. Some non-invasive intracranial pressure measurement methods are currently being studied; these would facilitate diagnostics of traumatic brain injury or other causes of intracranial hypertension without the risks associated with invasive modalities.
Due to the COVID-19 pandemic, the global Non-invasive Intracranial Pressure Monitoring Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Non-invasive Intracranial Pressure Monitoring Device market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Non-invasive Intracranial Pressure Monitoring Device landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Transcranial Doppler Ultrasonography accounting for % of the Non-invasive Intracranial Pressure Monitoring Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Traumatic Brain Injury segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Non-invasive Intracranial Pressure Monitoring Device include Medtronic, HaiWeiKang, HeadSense Medical, Vittamed and Chongqing Mingxi Medical Devices, etc. In terms of revenue, the global 3 largest players have a % market share of Non-invasive Intracranial Pressure Monitoring Device in 2021.
This report focuses on Non-invasive Intracranial Pressure Monitoring Device volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Non-invasive Intracranial Pressure Monitoring Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Non-invasive Intracranial Pressure Monitoring Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Transcranial Doppler Ultrasonography
Tympanic Membrane Displacement (TMD)
Optic Nerve Sheath Diameter
MRI/CT
Fundoscopy (Papilledema)
Segment by Application
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Subarachnoid Hemorrhage
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
HaiWeiKang
HeadSense Medical
Vittamed
Chongqing Mingxi Medical Devices